G
Power Law company profile
Gyroscope Therapeutics
Biotech & Life Sciences · London, United Kingdom · Founded 2016 Unicorn
Patent intelligence
$43M patent portfolio · 22 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$43M
5.5% of valuation · 164.5× smaller than top peer Janssen Vaccines ($7.1B)
22 active patent families
Where Gyroscope Therapeutics innovates
Biomedical engineeringAnatomyGeneral surgeryChoroidComplement factor I
Above peer median on Legal, Strategic, Market, Economic, Technology
Quality vs same-sector peers
Gyroscope Therapeutics on the five Patsnap quality dimensions
Gyroscope Therapeutics in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Gyroscope Therapeutics concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Gyroscope Therapeutics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Gyroscope Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.